Body height and late-life cognition among patients with atherothrombotic disease

Alzheimer Disease and Associated Disorders

Volumn 27, Issue 2, 2013, Pages 145-152

  Weinstein, Galit ^a   Goldbourt, Uri ^a   Tanne, David ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

atherosclerosis; cerebrovascular disease; cognition; cognition disorders; coronary disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATTENTION; BODY HEIGHT; BODY WEIGHT; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; THROMBOSIS;

AGED; BODY HEIGHT; COGNITION DISORDERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE;

EID: 84878892896     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31825ca9ef     Document Type: Article

References (39)

1. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995;311:171-174.
2. Goldbourt U, Tanne D. Body height is associated with decreased long-term stroke but not coronary heart disease mortality? Stroke. 2002;33:743-748.
3. Beeri MS, Davidson M, Silverman JM, et al. Relationship between body height and dementia. Am J Geriatr Psychiatry. 2005;13:116-123.
4. Huang TL, Carlson MC, Fitzpatrick AL, et al. Knee height and arm span: a reflection of early life environment and risk of dementia. Neurology. 2008;70(Pt 2):1818-1826.
5. Jeong SK, Kim JM, Kweon SS, et al. Does arm length indicate cognitive and functional reserve? Int J Geriatr Psychiatry. 2005;20:406-412.
6. Abbott RD, White LR, Ross GW, et al. Height as a marker of childhood development and late-life cognitive function: the Honolulu-Asia Aging Study. Pediatrics. 1998;102(3 Pt 1):602-609.
7. Snowdon DA, Kemper SJ, Mortimer JA, et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA. 1996;275:528-532.
8. Singh-Manoux A, Sabia S, Lajnef M, et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur Heart J. 2008;29:2100-2107.
9. The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation. 2000;102:21-27.
10. Goldbourt U, Brunner D, Behar S, et al. Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) Study. Eur Heart J. 1998;19(suppl H): H42-H47.
11. New York Heart Association. Criteria Committee, Dolgin M, Fox AC, Gorlin R, Levin RI, Devereaux RB. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston; London: Little, Brown; 1994.
12. Dwolatzky T, Whitehead V, Doniger GM, et al. Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr. 2003;3:4.
13. Doniger GM, Simon ES, Schweiger A. Adjustment of cognitive scores with a co-normed estimate of premorbid intelligence: implementation using mindstreams computerized testing. Appl Neuropsychol. 2008;15:250-263.
14. Fillit HM, Simon ES, Doniger GM, et al. Practicality of a computerized system for cognitive assessment in the elderly. Alzheimers Dement. 2008;4:14-21.
15. Muller M, Voges M, Piepgras U, et al. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Stroke. 1995;26:96-100.
16. Lawton MP, Brody EM. Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
17. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, ed. Clinical Gerontology: A Guide to Assessment and Intervention. New York: Haworth Press; 1986:165-173.
18. The American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
19. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541-553.
20. The R Development Core Team. R: A Language and Environment for Statistical Computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2003.
21. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289-300.
22. Kim JM, Stewart R, Shin IS, et al. Associations between head circumference, leg length and dementia in a Korean population. Int J Geriatr Psychiatry. 2008;23:41-48.
23. Kim JM, Stewart R, Shin IS, et al. Limb length and dementia in an older Korean population. J Neurol Neurosurg Psychiatry. 2003;74:427-432.
24. Silventoinen K. Determinants of variation in adult body height. J Biosoc Sci. 2003;35:263-285.
25. Silventoinen K, Kaprio J, Lahelma E, et al. Relative effect of genetic and environmental factors on body height: differences across birth cohorts among Finnish men and women. Am J Public Health. 2000;90:627-630.
26. Magnusson PK, Rasmussen F, Gyllensten UB. Height at age 18 years is a strong predictor of attained education later in life: cohort study of over 950,000 Swedish men. Int J Epidemiol. 2006;35:658-663.
27. Walker M, Shaper AG, Wannamethee G. Height and social class in middle-aged British men. J Epidemiol Commun Health. 1988;42:299-303.
28. Ferrie JE, Langenberg C, Shipley MJ, et al. Birth weight, components of height and coronary heart disease: evidence from the Whitehall II study. Int J Epidemiol. 2006;35: 1532-1542.
29. Batty GD, Shipley MJ, Gunnell D, et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol. 2009;7:137-152.
30. Crimmins EM, Finch CE. Infection, inflammation, height, and longevity. Proc Natl Acad Sci USA. 2006;103:498-503.
31. Sun C, Ponsonby AL, Wong TY, et al. Effect of birth parameters on retinal vascular caliber: the Twins Eye Study in Tasmania. Hypertension. 2009;53:487-493.
32. Tilling K, Lawlor DA, Davey Smith G, et al. The relation between components of adult height and intimal-medial thickness in middle age: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2006;164:136-142.
33. Branca F, Ferrari M. Impact of micronutrient deficiencies on growth: the stunting syndrome. Ann Nutr Metab. 2002;46(suppl 1):8-17.
34. Mendez MA, Adair LS. Severity and timing of stunting in the first two years of life affect performance on cognitive tests in late childhood. J Nutr. 1999;129:1555-1562.
35. Herschkowitz N. Neurological bases of behavioral development in infancy. Brain Develop. 2000;22:411-416.
36. Deijen JB, de Boer H, van der Veen EA. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology. 1998;23:45-55.
37. Kee F, Nicaud V, Tiret L, et al. Short stature and heart disease: nature or nurture? The EARS Group. Int J Epidemiol. 1997;26:748-756.
38. van den Heuvel DM, ten Dam VH, de Craen AJ, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry. 2006;77:149-153.
39. Johnson DK, Storandt M, Morris JC, et al. Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol. 2009;66:1254-1259.